Monitor for rapid selling by warrant holders given the massive overhang relative to market cap; any significant selling will likely crash the stock price. The cash from warrant exercises could extend operations but doesn't address the fundamental going concern issue.
Price Chart
Executive Summary
Aprea Therapeutics filed an S-3 shelf registration to allow resale of 74.3 million shares by selling stockholders from a March 2026 private placement, including pre-funded and common warrants. The company will not receive proceeds from the resale but may receive $25.4 million if all warrants are exercised for cash.
Key Financial Metrics
Key Facts
- S-3 registration covers resale of 74,349,426 shares by selling stockholders from a March 31, 2026 private placement
- Shares include 37.2 million underlying pre-funded warrants and 37.2 million underlying common warrants
- Company will not receive proceeds from resale but may receive $25.4 million if all warrants are exercised for cash
- Market cap is $10 million with stock trading at $0.91, meaning the registered shares represent 620% of current market cap
- Company has substantial doubt about continuing as a going concern per auditor
Financial Impact
Potential $25.4 million in cash proceeds if all warrants are exercised, but immediate dilution of 620% of market cap from registered shares
Risk Factors
- Massive shareholder overhang could crash stock price if selling occurs
- Company has substantial doubt about continuing as a going concern
- Potential for extreme volatility and dilution if warrants are exercised
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-046900 |
| Document: tm2612147d1_ex-filingfees.htm | 0001104659-26-046900 |
| Document: tm2612147d2_ex5-1.htm | 0001104659-26-046900 |
| Document: tm2612147d2_ex23-2.htm | 0001104659-26-046900 |
| Document: 0001104659-26-046900-index-headers.html | 0001104659-26-046900 |
| Document: 0001104659-26-046900-index.html | 0001104659-26-046900 |
| Document: 0001104659-26-046900.txt | 0001104659-26-046900 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 28, 2026 8w ago | 8-K | $0.8386 | awaiting T+60 | — | $0.5180 (−38.23%) |
Aug 12, 2026 10w ago | 8-K | $0.6830 | awaiting T+60 | — | $0.5180 (−24.16%) |
Aug 12, 2026 10w ago | Press Release | $0.6830 | awaiting T+60 | — | $0.5180 (−24.16%) |
May 13, 2026 23w ago | 8-K | $0.8800 $0.6503 | ▼ −26.10% | ▼ −30.54% | $0.5180 (−41.14%) |
May 13, 2026 23w ago | Press Release | $0.8800 $0.6503 | ▼ −26.10% | ▼ −30.54% | $0.5180 (−41.14%) |
Apr 30, 2026 25w ago | DEFA14A | $0.8000 $0.6247 | ▲ +21.91% | ▲ +25.02% | $0.5180 (+35.25%) |
Apr 22, 2026 26w ago | S-3 | $0.8840 $0.6690 | ▲ +24.32% | ▲ +29.34% | $0.5180 (+41.40%) |
Apr 21, 2026 26w ago | Press Release | $0.9070 $0.6900 | ▼ −23.93% | ▼ −30.82% | $0.5180 (−42.89%) |
Mar 31, 2026 29w ago | Insider Cluster | $0.7630 $0.7900 | ▲ +3.54% | ▼ −8.84% | $0.5180 (−32.11%) |
Mar 20, 2026 31w ago | EFFECT | $0.7620 $0.6990 | ▼ −8.27% | ▼ −22.69% | $0.5180 (−32.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers